Auristone is an Asian-based epigenomic profiling company powered with data analytics capabilities and extensive epigenomic know-how. We use our comprehensive portfolio of Asian epigenomic database to power data-driven drug and biomarker discoveries.
EPI-Call™ is our Flagship second generation Next Generation Sequencing (NGS) test. In addition to genomic information (DNA-seq), EPI-Call™ further provides epigenomic information around the tumour micro-environment and predicts patient response to immunotherapy. EPI-Call™ is the pragmatic choice to aid physicians in deciding the best treatment option for their patients.
We are committed to supporting clinical and academic epigenomic research, and moving such research outcomes into the clinical setting. Driven by our aspiration to improve the quality of life for patients through better treatment, we are continuously seeking ways to bring our technologies to our clinical and academic partners.
For more information on the company, drop us a line at enquiry@auristone.com or visit our website at www.auristone.com.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 73 Ayer Rajah Crescent, #02-10, Singapore 139952, Singapore,singapore
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.auristone.com
- HQ
- Singapore
Auristone Pte Ltd Questions
Auristone Pte Ltd's website is http://www.auristone.com
Auristone Pte Ltd's LinkedIn profile is https://sg.linkedin.com/company/auristone
Auristone Pte Ltd has
13 employees.
View email and phone details for 13
employees at Auristone Pte Ltd.
Auristone Pte Ltd's industry is
Biotechnology Research
Auristone Pte Ltd's top competitors are
Cogniant,
Mesh Bio,
Synapxe,
Sunbird Bio,
Biocheetah Pte Ltd,
Nalagenetics,
Avatamed,
Asia Genomics,
Luminicell,
Vivo Surgical.
Auristone Pte Ltd's categories are Biotechnology Research
Auristone Pte Ltd's founding year is 2021
